A new study using human pluripotent stem cell (hPSC)-derived human pancreatic organoids to model neoplastic transformation and cancer-derived human pancreatic tumor organoids for drug testing provides new personalized approaches to modeling and treating this malignancy.
References
Sato, T. et al. Nature 459, 262–265 (2009).
Spence, J.R. et al. Nature 470, 105–109 (2011).
Boj, S.F. et al. Cell 160, 324–338 (2015).
van de Wetering, M. et al. Cell 161, 933–945 (2015).
Ootani, A. et al. Nat. Med. 15, 701–706 (2009).
Huang, L. et al. Nat. Med. 21, 1364–1371 (2015).
Nostro, M.C. et al. Stem Cell Rep. 4, 591–604 (2015).
Matano, M. et al. Nat. Med. 21, 256–262 (2015).
Li, X. et al. Nat. Med. 20, 769–777 (2014).
Drost, J. et al. Nature 521, 43–47 (2015).
Gao, D. et al. Cell 159, 176–187 (2014).
Crystal, A.S. et al. Science 346, 1480–1486 (2014).
Kurian, A.W. Curr. Opin. Obstet. Gynecol. 22, 72–78 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
C.J.K. is an inventor on a pending patent describing organoid culture methodologies.
Rights and permissions
About this article
Cite this article
Zhang, H., Kuo, C. Personalizing pancreatic cancer organoids with hPSCs. Nat Med 21, 1249–1251 (2015). https://doi.org/10.1038/nm.3992
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3992
- Springer Nature America, Inc.
This article is cited by
-
The pivotal application of patient-derived organoid biobanks for personalized treatment of gastrointestinal cancers
Biomarker Research (2022)
-
The San Diego Nathan Shock Center: tackling the heterogeneity of aging
GeroScience (2021)
-
Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine
Experimental Hematology & Oncology (2018)
-
Organoid technology and applications in cancer research
Journal of Hematology & Oncology (2018)
-
Establishment and characterization of 6 novel patient-derived primary pancreatic ductal adenocarcinoma cell lines from Korean pancreatic cancer patients
Cancer Cell International (2017)